These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 16260151)
1. Purification and characterization of a recombinant anti-angiogenic kringle fragment expressed in Escherichia coli: Purification and characterization of a tri-kringle fragment from human apolipoprotein (a) (kringle IV (9)-kringle IV (10)-kringle V). Kang KY; Kim SG; Kim WK; You HK; Kim YJ; Lee JH; Jung KH; Kim CW Protein Expr Purif; 2006 Jan; 45(1):216-25. PubMed ID: 16260151 [TBL] [Abstract][Full Text] [Related]
2. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains. Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577 [TBL] [Abstract][Full Text] [Related]
3. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth. Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888 [TBL] [Abstract][Full Text] [Related]
4. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris. Zhou Y; Zheng Q; Gao J; Gu J Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125 [TBL] [Abstract][Full Text] [Related]
5. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system. Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375 [TBL] [Abstract][Full Text] [Related]
7. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278 [TBL] [Abstract][Full Text] [Related]
8. Purification of a bioactive recombinant human Reg IV expressed in Escherichia coli. Hu G; Shen J; Cheng L; Xiang D; Zhang Z; He M; Lu H; Zhu S; Wu M; Yu Y; Wang X; Han W Protein Expr Purif; 2010 Feb; 69(2):186-90. PubMed ID: 19699332 [TBL] [Abstract][Full Text] [Related]
9. Crystallization of antiangiogenic Kringle V derived from human apolipoprotein A: crystallization applied to purification and formulation. Kang KY; Park JH; Lim IH; Kim SG; Park SH; Kim WK; Hong JW; You HK; Jung KH; Kim CW Biosci Biotechnol Biochem; 2006 Apr; 70(4):916-25. PubMed ID: 16636459 [TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies. Richter W; Hermsdorf T; Kronbach T; Dettmer D Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709 [TBL] [Abstract][Full Text] [Related]
11. Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding. Hrzenjak A; Frank S; Maderegger B; Sterk H; Kostner GM Protein Eng; 2000 Sep; 13(9):661-6. PubMed ID: 11054461 [TBL] [Abstract][Full Text] [Related]
12. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies. Medynski D; Tuan M; Liu W; Wu S; Lin X Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563 [TBL] [Abstract][Full Text] [Related]
13. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli. Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102 [TBL] [Abstract][Full Text] [Related]
14. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2. Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli. Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585 [TBL] [Abstract][Full Text] [Related]
16. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli. Tan H; Dan G; Gong H; Cao L Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli. Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003 [TBL] [Abstract][Full Text] [Related]
18. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies. Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080 [TBL] [Abstract][Full Text] [Related]
19. Production and purification of TAL6003: a novel version of the protease plasmin. Aguda R; Caronna A; Hunt J; Koepf E; Lindsay M; Miller C; Rebbeor J; Silverstein R; Stokes K; Zimmerman T Protein Expr Purif; 2013 Mar; 88(1):41-6. PubMed ID: 23220455 [TBL] [Abstract][Full Text] [Related]
20. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]